Transferred WT1-Reactive CD8 + T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Donor-derived WT1-specific CD8 + T cells transferred after hematopoietic cell transplantation mediate antileukemic activity and can establish persistent responses without toxicity to normal tissues in high-risk leukemia patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Ki-67 protein: From the known and the unknown
Scholzen, T., & Gerdes, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3<311::aid-jcp1>3.0.co;2-9 · Cited by 4,646
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544
van Dongen, J. J. M., Langerak, A. W., Brüggemann, M., Evans, P. A. S., Hummel, M., Lavender, F. L., Delabesse, E., Davi, F., Schuuring, E., García-Sanz, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403202 · Cited by 3,043
Cancer regression in patients after transfer of genetically engineered lymphocytes
Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science · doi:10.1126/science.1129003 · Cited by 2,603 · cited 1×
“Strategies to accomplish this are becoming increasingly available, including suchmethods as transducing patient T cells with a characterized high-affinityWT1-specific T cell receptor (TCR) that imparts high avidity for leukemic targets, a technology already being used to target other antigens (42, 43).”
BackgroundLineage relationship and protective immunity of memory CD8 T cell subsets
Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni889 · Cited by 1,864
Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts
Weiden, P. L., Flournoy, N., Thomas, E. D., Prentice, R., Fefer, A., Buckner, C. D., & Storb, R. (1979) · New England Journal of Medicine · doi:10.1056/nejm197905103001902 · Cited by 1,510
Cheever, M. A., Allison, J. P., Ferris, A. S., Finn, O. J., Hastings, B. M., Hecht, T. T., Mellman, I., Prindiville, S. A., Viner, J. L., Weiner, L. M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0737 · Cited by 1,388
Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242600099 · Cited by 1,206
Self-citationRestoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E., & Greenberg, P. D. (1992) · Science · doi:10.1126/science.1352912 · Cited by 1,201
Self-citationTreatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
Hunder, N. N., Wallen, H., Cao, J., Hendricks, D. W., Reilly, J. Z., Rodmyre, R., Jungbluth, A., Gnjatic, S., Thompson, J. A., & Yee, C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800251 · Cited by 911
Self-citationThe candidate Wilms' tumour gene is involved in genitourinary development
Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D., et al. (1990) · Nature · doi:10.1038/346194a0 · Cited by 864
Berger, C., Jensen, M. C., Lansdorp, P. M., Gough, M., Elliott, C., & Riddell, S. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32103 · Cited by 824
Gratwohl, A., Hermans, J., Goldman, J., Arcese, W., Carreras, E., Devergie, A., Frassoni, F., Gahrton, G., Kolb, H., Niederwieser, D., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03030-x · Cited by 646
Cancer Immunotherapy: A Treatment for the Masses
Blattman, J. N., & Greenberg, P. D. (2004) · Science · doi:10.1126/science.1100369 · Cited by 612
Self-citationGeginat, J., Lanzavecchia, A., & Sallusto, F. (2003) · Blood · doi:10.1182/blood-2002-11-3577 · Cited by 601
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Rosenberg, S. A., & Dudley, M. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.03.002 · Cited by 595
The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo
Armstrong, J. F., Pritchard-Jones, K., Bickmore, W. A., Hastie, N. D., & Bard, J. B. L. (1993) · Mechanisms of Development · doi:10.1016/0925-4773(93)90090-k · Cited by 589
Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996. 274: 94-96.
Altman, J. D., Moss, P. A. H., Goulder, P., Barouch, D. H., McHeyzer‐Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (2011) · PubMed · Cited by 572
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Hinrichs, C. S., Spolski, R., Paulos, C. M., Gattinoni, L., Kerstann, K. W., Palmer, D. C., Klebanoff, C. A., Rosenberg, S. A., Leonard, W. J., & Restifo, N. P. (2008) · Blood · doi:10.1182/blood-2007-09-113050 · Cited by 462
Cilloni, D., Renneville, A., Hermitte, F., Hills, R. K., Daly, S., Jovanovic, J. V., Gottardi, E., Fava, M., Schnittger, S., Weiss, T., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.4865 · Cited by 445
Cui, W., Liu, Y., Weinstein, J. S., Craft, J., & Kaech, S. M. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.017 · Cited by 410
Selective elimination of leukemic CD34+ progenitor cells by cytotoxic T lymphocytes specific for WT1
Gao, L., Bellantuono, I., Elsässer, A., Marley, S. B., Gordon, M. Y., Goldman, J. M., & Stauss, H. J. (2000) · Blood · doi:10.1182/blood.v95.7.2198 · Cited by 408
Graft-versus-leukemia reactions in allogeneic chimeras
Kolb, H.-J., Schmid, C., Barrett, A. J., & Schendel, D. J. (2004) · Blood · doi:10.1182/blood-2003-02-0342 · Cited by 397
Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia
Inoue, K., Ogawa, H., Sonoda, Y., Kimura, T., Sakabe, H., Oka, Y., Miyake, S., Tamaki, H., Oji, Y., Yamagami, T., et al. (1997) · Blood · doi:10.1182/blood.v89.4.1405 · Cited by 371
Bergmann, L., Miething, C., Maurer, U., Brieger, J., Karakas, T., Weidmann, E., & Hoelzer, D. (1997) · Blood · doi:10.1182/blood.v90.3.1217 · Cited by 354
Deeg, H. J., Storer, B., Slattery, J. T., Anasetti, C., Doney, K. C., Hansen, J. A., Kiem, H.-P., Martin, P. J., Petersdorf, E., Radich, J. P., et al. (2002) · Blood · doi:10.1182/blood-2002-02-0527 · Cited by 284
Self-citationIL-21 Influences the Frequency, Phenotype, and Affinity of the Antigen-Specific CD8 T Cell Response
Li, Y., Bleakley, M., & Yee, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2261 · Cited by 273
Self-citationGyurkocza, B., Storb, R., Storer, B. E., Chauncey, T. R., Lange, T., Shizuru, J. A., Langston, A. A., Pulsipher, M. A., Bredeson, C. N., Maziarz, R. T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1460 · Cited by 210
Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
Oji, Y., Ogawa, H., Tamaki, H., Oka, Y., Tsuboi, A., Kim, E. H., Soma, T., Tatekawa, T., Kawakami, M., Asada, M., et al. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00733.x · Cited by 208
Ettinghausen, S., Moore, J., White, D., Platanias, L., Young, N., & Rosenberg, S. (1987) · Blood · doi:10.1182/blood.v69.6.1654.1654 · Cited by 167
Chapuis, A. G., Thompson, J. A., Margolin, K. A., Rodmyre, R., Lai, I. P., Dowdy, K., Farrar, E. A., Bhatia, S., Sabath, D. E., Cao, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113748109 · Cited by 163
Self-citationTopp, M. S., Riddell, S. R., Akatsuka, Y., Jensen, M. C., Blattman, J. N., & Greenberg, P. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021288 · Cited by 141
Self-citationOchsenbein, A. F., Riddell, S. R., Brown, M., Corey, L., Baerlocher, G. M., Lansdorp, P. M., & Greenberg, P. D. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040717 · Cited by 131
Self-citationChevallier, P., Labopin, M., Turlure, P., Prébet, T., Pigneux, A., Hunault, M., Filanovsky, K., Cornillet‐Lefèbvre, P., Luquet, I., Lodé, L., et al. (2011) · Leukemia · doi:10.1038/leu.2011.25 · Cited by 128
In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire
Ho, W., Nguyen, H., Wölfl, M., Kuball, J. H. E., & Greenberg, P. D. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.11.023 · Cited by 122
Self-citationPrognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse
Kurosawa, S., YAMAGUCHI, T., Miyawaki, S., Uchida, N., Sakura, T., Kanamori, H., Usuki, K., Yamashita, T., Okoshi, Y., Shibayama, H., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.027516 · Cited by 109
Establishment of Antitumor Memory in Humans Using in Vitro–Educated CD8 + T Cells
Butler, M. O., Friedlander, P. A., Milstein, M. I., Mooney, M. M., Metzler, G., Murray, A. P., Tanaka, M., Berezovskaya, A., Imataki, O., Drury, L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002207 · Cited by 107
Driessche, A. V., Berneman, Z. N., & Tendeloo, V. F. V. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0240 · Cited by 103
IL-21 Sustains CD28 Expression on IL-15-Activated Human Naive CD8+ T Cells
Alves, N. L., Arosa, F. A., & van Lier, R. A. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.755 · Cited by 98
Peters, J. H., Hilbrands, L. B., Koenen, H. J. P. M., & Joosten, I. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002233 · Cited by 90
Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
Larson, R. A. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2006.10.006 · Cited by 90
The Known, the Unknown and the Unknowable
Gomory, R. E. (1995) · Scientific American · doi:10.1038/scientificamerican0695-120 · Cited by 86
Kebriaei, P., Kline, J. P., Stock, W., Kasza, K., Beau, M. M. L., Larson, R. A., & van Besien, K. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704938 · Cited by 57
Bornhäuser, M., Thiede, C., Platzbecker, U., Kiani, A., Oelschlaegel, U., Babatz, J., Lehmann, D., Hölig, K., Radke, J., Tuve, S., et al. (2011) · Blood · doi:10.1182/blood-2010-09-308569 · Cited by 53
Ragheb, J. A., Deen, M., & Schwartz, R. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.120 · Cited by 48
The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed
Popović, J., Li, L., Kloetzel, P. M., Leisegang, M., Uckert, W., & Blankenstein, T. J. F. (2011) · Blood · doi:10.1182/blood-2010-12-325035 · Cited by 41
Marr, L. A., Gilham, D. E., Campbell, J. D. M., & Fraser, A. R. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04517.x · Cited by 26
Cell permeabilization for the assessment of T lymphocyte polyfunctional capacity
Papagno, L., Almeida, J. R., Nemes, E., Autran, B., & Appay, V. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.09.001 · Cited by 20
Unfavorable-risk cytogenetics in acute myeloid leukemia
Hong, W., & Medeiros, B. C. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.10 · Cited by 16
Cited by
Döhner, H., Estey, E., Grimwade, D., Amadori, S., Appelbaum, F. R., Büchner, T., Dombret, H., Ebert, B. L., Fenaux, P., Larson, R. A., et al. (2017) · Blood · doi:10.1182/blood-2016-08-733196 · Cited by 5,775
Adoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P., & Boon, T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3670 · Cited by 1,138
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Anderson, K. G., Stromnes, I. M., & Greenberg, P. D. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.008 · Cited by 702
Self-citationNavigating CAR-T cells through the solid-tumour microenvironment
Hou, A. J., Chen, L. C., & Chen, Y. Y. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00189-2 · Cited by 551
Metadata
- Authors
- Chapuis, A. G., Ragnarsson, G. B., Nguyen, H. N., Chaney, C. N., Pufnock, J. S., Schmitt, T. M., Duerkopp, N., Roberts, I. M., Pogosov, G. L., Ho, W. Y., Ochsenreither, S., Wölfl, M., Bar, M., Radich, J. P., Yee, C., & Greenberg, P. D.
- Venue
- Science Translational Medicine
- Published
- 2013-02-27
- Volume
- 5
- Issue
- 174
- Pages
- 174ra27-174ra27
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2129676200
- Cited by
- 311
- References
- 49
- FWCI
- 24.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.